Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis With Endoscopically Normal Mucosa
暂无分享,去创建一个
T. Hibi | S. Morinaga | T. Hisamatsu | Taku Kobayashi | A. Hara | E. Saito | S. Okabayashi | M. Nakano | R. Ozaki | M. Ohbu | T. Toyonaga | K. Matsuoka | Shinji Okabayashi
[1] R. Pinho,et al. Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis , 2017, Inflammatory bowel diseases.
[2] D. Rubin,et al. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[3] L. Laine,et al. Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis , 2016, The American Journal of Gastroenterology.
[4] P. Higgins,et al. Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis , 2016, Inflammatory bowel diseases.
[5] G. Krolow,et al. Aortic Occlusion in a Patient With Gastrointestinal Symptoms , 2016, The American Journal of Gastroenterology.
[6] L. Stitt,et al. Development and validation of a histological index for UC , 2015, Gut.
[7] S. Travis,et al. Development and validation of the Nancy histological index for UC , 2015, Gut.
[8] B. Warren,et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up , 2015, Gut.
[9] A. Bitton,et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus. , 2015, Gastroenterology.
[10] S. Travis,et al. Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative. , 2014, Journal of Crohn's & colitis.
[11] B. Korelitz,et al. Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis. , 2014, World journal of gastroenterology.
[12] M. Vandervoort,et al. Histologic Evaluation of Ulcerative Colitis: A Systematic Review of Disease Activity Indices , 2014, Inflammatory bowel diseases.
[13] D. Rubin,et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[14] G. Petris,et al. European consensus on the histopathology of inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.
[15] A. Cheifetz,et al. Histologic markers of inflammation in patients with ulcerative colitis in clinical remission. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[16] B. Flourié,et al. Impact of mucosal healing on long‐term outcomes in ulcerative colitis treated with infliximab: a multicenter experience , 2013, Alimentary pharmacology & therapeutics.
[17] P. Rutgeerts,et al. Correlation Between the Endoscopic and Histologic Score in Assessing the Activity of Ulcerative Colitis , 2013, Inflammatory bowel diseases.
[18] P. Rutgeerts,et al. Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing , 2012, The American Journal of Gastroenterology.
[19] R. D'Incà,et al. Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study , 2012, Inflammatory bowel diseases.
[20] E. Kuipers,et al. Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation , 2011, Inflammatory bowel diseases.
[21] Q Wang,et al. Differentiation of colonic polyps by confocal laser endomicroscopy. , 2011, Endoscopy.
[22] N. Harpaz,et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. , 2007, Gastroenterology.
[23] M. Vatn,et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. , 2007, Gastroenterology.
[24] Philippe Marteau,et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. , 2007, Gastroenterology.
[25] A. Öst,et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis , 2000, Gut.
[26] S. Riley,et al. Microscopic activity in ulcerative colitis: what does it mean? , 1991, Gut.
[27] R. Willén,et al. Histologic and colonoscopic assessment of disease extension in ulcerative colitis. , 1987, Scandinavian journal of gastroenterology.
[28] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[29] S. Truelove,et al. Biopsy Studies in Ulcerative Colitis , 1956, British medical journal.
[30] W. Sandborn. Mucosal healing in inflammatory bowel disease. , 2008, Reviews in gastroenterological disorders.
[31] A. Cohen,et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. , 2001, Gastroenterology.